Micron Reaches 1 Trillion Market Cap as AI Memory Demand Surges Traders Bet on IonQ Micron Anduril as Next Potential Government Stake Targets April Private Payrolls Rise 109000 Exceeding Expectations ADP Report Signals Steady Labor Market Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales The Home Depot HD Shows Resilience Amid Market Headwinds Says TD Cowen IRFC Secures 13527 Crore Refinancing Deal for Hyderabad Metro Shares Gain 4 REGCP Q1 2026 Earnings EPS Beats Estimates by 736 Preferred Shares Edge Lower TRP Q1 2026 Earnings NearMiss on EPS with Modest Stock Uptick ATAI Q1 2026 Earnings Narrower Loss Beats Estimates Stock Edges Higher Insulet Corporation PODD Q1 2026 Earnings EPS Surges Past Estimates Despite Slight Stock Pullback ASTS Q1 2026 Earnings PreRevenue Company Misses Deeply on EPS Yet Shares Rally on Operational Milestones FIS Q1 2026 Earnings EPS Surpasses Estimates Stock Slightly Lower Janus Henderson Group JHG Holds Steady Near 52 as Key Levels Loom Brighthouse Financial BHF Holds Steady Amid Modest Decline Key Levels in Focus High Income Securities Fund PCF Holds Steady Near Support Amid Low Volatility AudioEye Inc AEYE Edges Lower as Shares Test Key Support Levels PermRock Royalty Trust PRT Nears Key Support as Price Slips Slightly The Mandalorian and Grogu A Critical and Commercial Catalyst for Disneys Star Wars Franchise First Citizens BancShares FCNCA Q1 2026 Earnings Strong EPS Beat Highlights Resilient Core Operations Sleep Number Corporation SNBR Bounces from Support Potential Reversal or Temporary Relief Carlyle Group Q1 2026 Earnings Missed EPS Expectations Amid Volatile Markets STKS Q1 2026 Earnings Widening Losses as EPS Misses Estimates by 146 FNF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Real Estate Environment SION Q1 2026 Earnings EPS Misses Consensus as PreRevenue Biotech Advances Pipeline Stock Edges Higher MGX Q1 2026 Earnings EPS Miss Reflects Increased RD Spending Amid Pipeline Progress Actinium Pharmaceuticals ATNM Q1 2026 Earnings Narrower Loss Beats Expectations as Development Pipeline Advances Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues